Michael Wang
Philadelphia College of Osteopathic Medicine(US)Creighton University(US)Central Michigan University(US)Duke University(US)St. Joseph Health System(US)
Publications by Year
Research Areas
Lymphoma Diagnosis and Treatment, Chronic Lymphocytic Leukemia Research, CAR-T cell therapy research, Multiple Myeloma Research and Treatments, Viral-associated cancers and disorders
Most-Cited Works
- → Lisocabtagene maraleucel for patients with relapsed or refractory large B-cell lymphomas (TRANSCEND NHL 001): a multicentre seamless design study(2020)2,247 cited
- → Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors(2020)2,047 cited
- → KTE-X19 CAR T-Cell Therapy in Relapsed or Refractory Mantle-Cell Lymphoma(2020)1,759 cited
- → Targeting BTK with Ibrutinib in Relapsed or Refractory Mantle-Cell Lymphoma(2013)1,668 cited
- → Chemotherapy-Refractory Diffuse Large B-Cell Lymphoma and Indolent B-Cell Malignancies Can Be Effectively Treated With Autologous T Cells Expressing an Anti-CD19 Chimeric Antigen Receptor(2014)1,600 cited
- → Carfilzomib, Lenalidomide, and Dexamethasone for Relapsed Multiple Myeloma(2014)1,316 cited